Subscribe To
Google stock could rally after q2: 3 reasons why
After Snap's below-consensus earnings report, Google sold off more than 5% (-$76 billion market cap). The market is implying a ...
July 25, 2022, 1:44 pm
Here's 1 way inflation is affecting roku
Rising costs have been negatively impacting the streaming platform provider....
July 25, 2022, 6:37 am
Stock market today: stocks' momentum stalls after shocking snap earnings
The Nasdaq's impressive multi-day winning streak came to a screeching halt on Friday as a negative earn...
July 22, 2022, 4:17 pm
Northrim bancorp: high oil prices, interest rates to salvage earnings
The negative loan trend will likely reverse soon due to the ending of PPP forgiveness and high oil pric...
July 21, 2022, 5:16 pm
We upgrade target from hold to buy
In our last article, we rated TGT as hold, due to its overvaluation. Since then, its stock price has fallen by about 27%, making the stock much more a...
July 21, 2022, 2:11 pm
S4 capital sinks as sorrell's outfit slashes forecasts
S4 Capital piled on the agony for its investors today as Martin Sorrell's acquisitive firm lowered its forecasts for the year due to rising costs from...
July 21, 2022, 8:06 am
Origin materials: leading carbon negative materials player with huge growth potential
The company's proprietary and leading platform technology enables companies to lower their carbon footprint while still matching the product performan...
July 20, 2022, 2:18 pm
Car market outlook: recovery postponed again
We are revising our global car sales forecasts for 2022 into negative territory. While we had hoped tha...
July 20, 2022, 1:38 pm
Biodesix to present data at iaslc 2022 world conference demonstrating that the veristrat® test is predictive of progression free survival and overall survival in patients with low or negative pd-l1 tr
BOULDER, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a foc...
July 20, 2022, 6:00 am
Johnson & johnson has been posting negative surprises: a look under the hood
JNJ Management expects relatively consistent growth for the rest of the year....
July 18, 2022, 8:06 pm
Spy: face it - the market is getting more resilient and this is bullish
SPY is grinding higher despite the negative news and downgrades. The June 17th bottom is still holding,...
July 18, 2022, 6:46 am
Schwab: valuation down but higher rates and acquisition synergies driving earnings growth
Positive, long-term wealth management industry fundamentals remain intact, and my expectation of earnings growth from higher interest rates and Amerit...
July 16, 2022, 8:07 am
Unity software: the doom and gloom takes over
I recently wrote about how the market is being far too negative when it came to Unity Software, and is ...
July 15, 2022, 3:06 pm
Switzerland hikes rate first time since 2007: etf in focus
The Swiss National Bank raised its policy rate by 50 bps to negative 0.25%....
July 15, 2022, 9:05 am
Rolls-royce and bae to see increased defence spending whoever wins tory election
Increased spending on UK defence is unlikely to be affected by whoever wins the Tory party election race, according to analysts at US bank Citi. “We...
July 14, 2022, 9:47 am
Despite the macroeconomic headwinds, we maintain our buy rating on crocs
Macroeconomic headwinds, including declining consumer confidence, the strong USD and elevated costs, may negatively impact Crocs' financial performanc...
July 14, 2022, 6:02 am
Apple, amazon, tesla stocks dive into the red after inflation data
Shares of technology behemoths, and electric vehicle maker Tesla Inc. TSLA, -0.54% , pulled sharp U-turns in premarket trading to dive into ...
July 13, 2022, 8:56 am
Nio stock gains as china's ministry offers tax breaks for new ev owners
Over the past weekend, China introduced new Covid-19 restrictions, which had a negative effect on elect...
July 11, 2022, 10:18 am
Cresco labs: cannabis business held by political impasse
The political impasse surrounding the decriminalization of cannabis has largely affected the growth of the business as compared to rising US inflation...
July 11, 2022, 2:42 am
Harpoon therapeutics: a t-cell engager platform and a negative enterprise value makes it a candidate for my 'bio boom' portfolio
Harpoon Therapeutics has an intriguing platform that can generate stable bispecific immunotherapies using their TriTAC technology. Their “off-the-sh...
July 7, 2022, 5:34 pm
